166 related articles for article (PubMed ID: 16046401)
1. T-oligo treatment decreases constitutive and UVB-induced COX-2 levels through p53- and NFkappaB-dependent repression of the COX-2 promoter.
Marwaha V; Chen YH; Helms E; Arad S; Inoue H; Bord E; Kishore R; Sarkissian RD; Gilchrest BA; Goukassian DA
J Biol Chem; 2005 Sep; 280(37):32379-88. PubMed ID: 16046401
[TBL] [Abstract][Full Text] [Related]
2. T-oligos augment UV-induced protective responses in human skin.
Arad S; Konnikov N; Goukassian DA; Gilchrest BA
FASEB J; 2006 Sep; 20(11):1895-7. PubMed ID: 16877521
[TBL] [Abstract][Full Text] [Related]
3. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells.
Han S; Inoue H; Flowers LC; Sidell N
Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of interleukin-1beta-induced cyclooxygenase 2 expression in human synovial fibroblasts by 15-deoxy-Delta12,14-prostaglandin J2 through a histone deacetylase-independent mechanism.
Farrajota K; Cheng S; Martel-Pelletier J; Afif H; Pelletier JP; Li X; Ranger P; Fahmi H
Arthritis Rheum; 2005 Jan; 52(1):94-104. PubMed ID: 15641079
[TBL] [Abstract][Full Text] [Related]
5. The involvement of NF-kappaB in the constitutive overexpression of cyclooxygenase-2 in cyclooxygenase-1 null cells.
Kanekura T; Goorha S; Kirtikara K; Ballou LR
Biochim Biophys Acta; 2002 Jan; 1542(1-3):14-22. PubMed ID: 11853875
[TBL] [Abstract][Full Text] [Related]
6. Dynamic regulation of cyclooxygenase-2 promoter activity by isoforms of CCAAT/enhancer-binding proteins.
Zhu Y; Saunders MA; Yeh H; Deng WG; Wu KK
J Biol Chem; 2002 Mar; 277(9):6923-8. PubMed ID: 11741938
[TBL] [Abstract][Full Text] [Related]
7. COX-2 expression is induced by UVB exposure in human skin: implications for the development of skin cancer.
Buckman SY; Gresham A; Hale P; Hruza G; Anast J; Masferrer J; Pentland AP
Carcinogenesis; 1998 May; 19(5):723-9. PubMed ID: 9635856
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type-1 Tat/co-activator acetyltransferase interactions inhibit p53Lys-320 acetylation and p53-responsive transcription.
Harrod R; Nacsa J; Van Lint C; Hansen J; Karpova T; McNally J; Franchini G
J Biol Chem; 2003 Apr; 278(14):12310-8. PubMed ID: 12501250
[TBL] [Abstract][Full Text] [Related]
9. Role of cyclic AMP responsive element in the UVB induction of cyclooxygenase-2 transcription in human keratinocytes.
Tang Q; Chen W; Gonzales MS; Finch J; Inoue H; Bowden GT
Oncogene; 2001 Aug; 20(37):5164-72. PubMed ID: 11526505
[TBL] [Abstract][Full Text] [Related]
10. Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.
Huang SM; McCance DJ
J Virol; 2002 Sep; 76(17):8710-21. PubMed ID: 12163591
[TBL] [Abstract][Full Text] [Related]
11. Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms.
Subbaramaiah K; Cole PA; Dannenberg AJ
Cancer Res; 2002 May; 62(9):2522-30. PubMed ID: 11980644
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia induces high-mobility-group protein I(Y) and transcription of the cyclooxygenase-2 gene in human vascular endothelium.
Ji YS; Xu Q; Schmedtje JF
Circ Res; 1998 Aug; 83(3):295-304. PubMed ID: 9710122
[TBL] [Abstract][Full Text] [Related]
13. Activation of NFkappaB is necessary for IL-1beta-induced cyclooxygenase-2 (COX-2) expression in human gingival fibroblasts.
Nakao S; Ogata Y; Shimizu-Sasaki E; Yamazaki M; Furuyama S; Sugiya H
Mol Cell Biochem; 2000 Jun; 209(1-2):113-8. PubMed ID: 10942208
[TBL] [Abstract][Full Text] [Related]
14. Cyclooxygenase-2 expression and prostaglandin E2 biosynthesis are enhanced in scleroderma fibroblasts and inhibited by UVA irradiation.
Kanekura T; Higashi Y; Kanzaki T
J Rheumatol; 2001 Jul; 28(7):1568-72. PubMed ID: 11469463
[TBL] [Abstract][Full Text] [Related]
15. Human T-lymphotropic virus type I Tax protein utilizes distinct pathways for p53 inhibition that are cell type-dependent.
Pise-Masison CA; Mahieux R; Radonovich M; Jiang H; Brady JN
J Biol Chem; 2001 Jan; 276(1):200-5. PubMed ID: 11036071
[TBL] [Abstract][Full Text] [Related]
16. Trichostatin A induces transforming growth factor beta type II receptor promoter activity and acetylation of Sp1 by recruitment of PCAF/p300 to a Sp1.NF-Y complex.
Huang W; Zhao S; Ammanamanchi S; Brattain M; Venkatasubbarao K; Freeman JW
J Biol Chem; 2005 Mar; 280(11):10047-54. PubMed ID: 15647279
[TBL] [Abstract][Full Text] [Related]
17. Telomeric DNA induces p53-dependent reactive oxygen species and protects against oxidative damage.
Lee MS; Yaar M; Eller MS; RĂ¼nger TM; Gao Y; Gilchrest BA
J Dermatol Sci; 2009 Dec; 56(3):154-62. PubMed ID: 19906512
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor alpha (TNF-alpha)-induced prostaglandin E2 release is mediated by the activation of cyclooxygenase-2 (COX-2) transcription via NFkappaB in human gingival fibroblasts.
Nakao S; Ogtata Y; Shimizu E; Yamazaki M; Furuyama S; Sugiya H
Mol Cell Biochem; 2002 Sep; 238(1-2):11-8. PubMed ID: 12349897
[TBL] [Abstract][Full Text] [Related]
19. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast expression of the coactivator p300 governs the intensity of profibrotic response to transforming growth factor beta.
Bhattacharyya S; Ghosh AK; Pannu J; Mori Y; Takagawa S; Chen G; Trojanowska M; Gilliam AC; Varga J
Arthritis Rheum; 2005 Apr; 52(4):1248-58. PubMed ID: 15818659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]